The fall in Aarti Drugs share price came after the company reported a weak set of September quarter (Q2FY25) earnings.
Smallcap pharmaceutical company Aarti Drugs's shares climbed up to 2.95 per cent at Rs 528.85 per share on the BSE
Going ahead in FY25, the management anticipates an improvement in margins, mostly driven by an anticipated growth in export sales and backward integration.